ADP Research Highlights Sustained Growth in Knowledge Work Across Global Labor Markets Red Sox 55M Pitcher Faces Uncertain Future Amid Superstar Return AIEnhanced Drug Discovery May Accelerate Development of Treatments for Neurological Conditions Market Eyes Iran Deal Progress Tesla and AI Stocks Approach Key Levels 15 Cities with the Worlds Best Public Transit Economic and Investment Implications Cricket Fandom Goes Digital Fan Tokens Could Be the Next Big Play in Sports Engagement Nasdaq Inc NDAQ Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Decline PodcastOne Inc PODC Q1 2026 Earnings Profitability Surprise Drives 9 Stock Rally WSBCO Q1 2026 Earnings Preferred Stock Series B Beats EPS Estimates Amid Stable Operations THCH Q4 2025 Earnings Deep Loss Reported Amidst Limited Disclosure JBSS Q1 2026 Earnings EPS Surprises to the Upside Beating Estimates by Over 21 Precision BioSciences DTIL Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported Stock Edges Higher Nu Skin Edges Lower as Shares Test Key Support Level Inflection Point Acquisition Corp III Rights IPCXR Edges Higher Amid Modest Trading Activity UP Fintech TIGR Declines 137 as Price Approaches Key Support Zone Radiopharm Theranostics RADX Gains Ground Testing Key Resistance at 485 Velocity Financial VEL Consolidates Near 1743 as Traders Eye Support and Resistance Levels Contineum Therapeutics Inc CTNM Q1 2026 Earnings ClinicalStage Biotech Reports Narrower Loss Shares Dip Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue AvalonBay Communities Q1 2026 Earnings Massive EPS Beat Driven by Strong Operations SPME Q1 2026 Earnings EPS Misses Estimates by Nearly 20 as Preferred Shares Edge Lower National Bankshares Inc NKSH Q4 2025 Earnings Strong EPS Beat Amid Steady Operations Nasdaq Inc NDAQ Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Decline OpenAI Sets Sights on IPO as AI Competition Heats Up Confidential Filing Reportedly Imminent NRP Q1 2026 Earnings LP Reports Solid EPS Amid Quiet Market Response Clover Health CLOV Surges Over 12 as Momentum Breaks Above Key Resistance